TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.

William Kevin Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.